We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$14.9B
AUM Growth
+$734M
(+5.2%)
Cap. Flow
-$271M
Cap. Flow
% of AUM
-1.83%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
304
New
43
Increased
101
Reduced
105
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$215M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Microsoft
MSFT
|
+$163M |
| 4 |
Biogen
BIIB
|
+$147M |
| 5 |
Synchrony
SYF
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$236M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$227M |
| 3 |
AbbVie
ABBV
|
+$169M |
| 4 |
Yum! Brands
YUM
|
+$147M |
| 5 |
Analog Devices
ADI
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.21% |
| 2 | Technology | 15.59% |
| 3 | Consumer Discretionary | 15.51% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 11.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBTM
201
JBT Marel
JBTM
$6.35B
| $10.1M | 0.07% |
+202,391
| New | +$9.19M |
|
|
CCXI
202
DELISTED
ChemoCentryx, Inc.
CCXI
| $8.93M | 0.06% |
1,102,332
+19,375
| +2% | +$137K |
|
|
PSIX
203
Power Solutions International
PSIX
$759M
| $8.39M | 0.06% |
459,972
-97,965
| -18% | -$2.11M |
|
204
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $8.39M | 0.06% |
60,256
+50,956
| +548% | +$7.23M |
|
205
Travel + Leisure Co
TNL
$4.77B
| $7.78M | 0.05% |
237,209
+25,628
| +12% | +$884K |
|
206
First American
FAF
$7.66B
| $7.38M | 0.05% |
205,676
+22,230
| +12% | +$849K |
|
207
AstraZeneca
AZN
$250B
| $7.24M | 0.05% |
106,675
+11,225
| +12% | +$736K |
|
208
Cisco
CSCO
$479B
| $7.07M | 0.05% |
260,225
+28,110
| +12% | +$776K |
|
209
Jack Henry & Associates
JKHY
$11B
| $6.85M | 0.05% |
87,772
+9,400
| +12% | +$722K |
|
210
Flowers Foods
FLO
$1.57B
| $6.85M | 0.05% |
318,740
+134,320
| +73% | +$3.27M |
|
211
Paychex
PAYX
$42.1B
| $6.46M | 0.04% |
122,112
+13,100
| +12% | +$685K |
|
212
CME Group
CME
$95.2B
| $6.18M | 0.04% |
68,220
+7,250
| +12% | +$682K |
|
|
GIMO
213
DELISTED
Gigamon Inc.
GIMO
| $5.8M | 0.04% |
+218,249
| New | +$5.61M |
|
214
Bank of America
BAC
$442B
| $5.78M | 0.04% |
343,650
| – | – |
|
215
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $5.64M | 0.04% |
+122,830
| New | +$5.71M |
|
216
Keurig Dr Pepper
KDP
$41.8B
| $5.6M | 0.04% |
60,071
+6,480
| +12% | +$575K |
|
217
Pfizer
PFE
$147B
| $5.23M | 0.04% |
170,722
+15,990
| +10% | +$503K |
|
218
PepsiCo
PEP
$189B
| $5.21M | 0.04% |
52,142
+7,540
| +17% | +$752K |
|
219
Kimberly-Clark
KMB
$37.3B
| $5.19M | 0.03% |
40,791
+4,260
| +12% | +$511K |
|
|
PACW
220
DELISTED
PacWest Bancorp
PACW
| $5.02M | 0.03% |
116,530
+12,480
| +12% | +$561K |
|
221
Everest Group
EG
$14.3B
| $4.96M | 0.03% |
+27,100
| New | +$4.92M |
|
222
Boeing
BA
$190B
| $4.91M | 0.03% |
33,930
+300
| +0.9% | +$43.2K |
|
223
Ecolab
ECL
$80.3B
| $4.48M | 0.03% |
+39,140
| New | +$4.6M |
|
224
Verizon
VZ
$193B
| $4.39M | 0.03% |
+95,055
| New | +$4.32M |
|
|
AGN
225
DELISTED
Allergan plc
AGN
| $4.24M | 0.03% |
13,560
-5,770
| -30% | -$1.72M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Westfield Capital Management held 304 positions worth $14.9B, up 5.2% from $14.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Westfield Capital Management's Q4 2015 filing shows 43 new, 101 increased, 105 reduced and 32 closed positions. Its largest new stake was Alphabet (Google) Class A: 5,804,860 shares worth $226M. The largest sale was Vertex Pharmaceuticals, an estimated $236M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,804,860 shares worth $226M.
- Westfield Capital Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $184M increase.
- Westfield Capital Management's biggest Q4 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $236M.
- Westfield Capital Management fully exited Analog Devices in Q4 2015, selling an estimated $129M.
- Westfield Capital Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2015.
- Westfield Capital Management opened 43 new positions and closed 32 in Q4 2015.
- Westfield Capital Management's portfolio value rose 5.2% quarter-over-quarter to $14.9B.
Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.